Glenmark was established with the goal of becoming a prominent, research-driven global pharmaceutical company. Our branded generics business holds a strong position in emerging markets, particularly in India. Additionally, our generics business caters to the needs of developed markets such as the US and Western Europe. In the API (Active Pharmaceutical Ingredient) sector, we distribute products to more than 65 countries, encompassing the US, various EU nations, South America, and India.
